ArticleBMC cardiovascular disorders2025
Global, regional, and national burden of endocarditis, 1990-2021: a systematic analysis of the GBD 2021 study.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Changing Patterns in Infective Endocarditis: A Contemporary Epidemiological Perspective.Pathogens (Basel, Switzerland) · 2026Review
- In-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Mexican Tertiary University Hospital.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEndocarditis is a serious cardiovascular infection associated with high mortality and disability. Its global epidemiological patterns and long-term trends have not been comprehensively characterized.
methodsData from the Global Burden of Disease (GBD) Study 1990-2021 were used to evaluate the prevalence, incidence, disability-adjusted life years (DALYs), and Deaths of endocarditis across 204 countries and territories. Temporal trends were analyzed using percentage change and estimated annual percentage change (EAPC), stratified by Socio-demographic Index (SDI), region, age, and sex.
resultsBetween 1990 and 2021, the absolute number of endocarditis cases increased: prevalence by 14%, incidence by 34%, DALYs by 26%, and Deaths by 29%. Conversely, age-standardized rates declined (EAPCs: -0.58 for prevalence, -0.09 for incidence, -0.33 for DALYs, -0.29 for Deaths). Females had higher prevalence and incidence, while males experienced greater Deaths and DALYs burdens. The burden was concentrated among individuals aged ≥ 65 years, with slight increases observed in children under 5 in low-SDI regions. High-SDI regions showed declining trends in age-standardized metrics, whereas low- and middle-SDI regions exhibited increases. Correlation analysis indicated a moderate association between SDI and prevalence (R = 0.543), a stronger association with incidence (R = 0.770), and a weak correlation with DALYs (R = 0.063).
conclusionsThe absolute burden of endocarditis has increased globally despite declining standardized rates, with older adults and low-SDI populations disproportionately affected. These findings highlight the need for enhanced surveillance and equitable access to care, although limited clinical detail in the GBD framework restricts direct clinical interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.